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ABSTRACT 
Nowadays biomedical research is generating huge amounts of omic data, covering all levels of genetic information 
from nucleotide sequencing to protein metabolism. In the beginning, data were analyzed independently losing a great 
deal of essential information in the models. Even so, complex metabolic routes and genetic diseases could be 
determined. In the last decade, there has been an ever-increasing number of research projects that follow a systemic 
biological approach by integrating multiple omic datasets obtaining more complex, powerful and informative models 
that provide a deeper knowledge about the genotype-phenotype interactions. These models greatly contributed to the 
study of complex multi- factorial diseases such as cancer. The onset and development of any type of cancer can be 
influenced by multiple variables. Integrate as many as possible omic datasets is therefore the best approach to extract 
all the underlying knowledge. A significant factor in the mortality of this disease is the metastatic process. The 
identification of the factors involved in this cell behavior may be helpful in the diagnosis and hopefully in the disease 
prevention.  
The development of novel integrative multiomics approaches is an opportunity to fill the gaps between our ability to 
generate data and the difficulties to understand the biology behind them. In this work we propose a methodology 
pipeline for analyze multi-omics data using machine learning.  
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1 INTRODUCTION 
Omics in Molecular Biology refers to the study of the whole of something. Omics aims at the 
collective characterization and quantification of sets of biological molecules that are translated into the 
structure, function and dynamics of an organism or several organisms at the same time.  
 
In the beginning, these different sources of omic data were analyzed separately by means of 
conventional statistical techniques to contrast hypotheses in order to obtain those variables that have the 
most biological significance. Nowadays, Artificial Intelligence algorithms are being presented as an 
alternative to this analysis. These techniques, which basically learn through examples, give researchers 
the ability to analyze and extract knowledge of huge amounts of data at the same time, independently of 
the dimension of the problem. Furthermore, this would not be possible with conventional statistical 
approaches in which the usual tests are not designed for data sets of such high dimensionality [11].  
 
Due to the emergence of Next Generation Sequencing (NGS) techniques and moreover to the drastic 
reduction of the economical costs of the process, there is for example a growing amount of open access 
data for the study and characterization of each type of cancer and its different related biological processes. 
Therefore, more efforts are necessary for the analysis of these sources of omic data.  
 
These models greatly contribute to the study of complex multifactorial diseases such as cancer. The 
onset and development of any type of cancer can be influenced by multiple factors so the consideration 
the as much of these sources as possible is probably the best way to go. Furthermore, a critical factor in 
the mortality of this disease is the metastatic process. Therefore, the identification of some of the factors 
significantly associated to this cell behavior may be of great help in the diagnosis and the characterization 
of subtypes of the same cancer.  
 
Metastasis is the most fatal characteristic of malignancy tumor, which is directly related with more 
than 90% of tumor-related mortality. Distant organ or tissue metastasis is a sign of poor prognosis in 
patients with cancer. Cancer cells spreads to other parts of the body through bloodstream or lymph 
system. Either way, most of the escaped cancer cells die or are killed before they can start growing 
somewhere else. But one or two might settle in a new area, begin to grow, and form new tumors. The 
development of a cancer staging system help clinicians with prognosis and allow them to design a 
treatment plan for individual patients. Therefore, be able to classify a patient according to the cancer 
stage, will improve early diagnose methods and treatments. Regarding cancers that already have some 
type of metastasis the TNM Staging System is the most used system for diagnosis. TNM is based on the 
extent of the tumor (T), the extent of spread to the lymph nodes (N), and the presence of metastasis (M). 
Therefore the T category describes the original (primary) tumor, the N category describes whether or not 
the cancer has reached nearby lymph nodes and M category tells whether there are distant metastases 
(spread of cancer to other parts of the body).  
 
In this context, Machine Learning (ML) techniques can help the clinicians in the diagnosis and 
treatment of cancer patients. Because of the complexity of the problem, it is necessary to have the as 
much sources of omic data as possible, integrating them in the same analytic process. In recent years there 
has been an increase in the number of scientific research proposals that follow a systemic biologic 
approach, integrating different sources of omic data [4]. Thereby, we are able to obtain more powerful 
models that give us greater knowledge about the interaction between phenotype and genotype [7].  
 
Unfortunately, for this type of analysis there is no standardized methodology. Therefore, it is 
necessary to detail and specify a coherent analysis methodology for this type of integrative bioinformatic 
analysis [2] using machine learning and artificial intelligence.  
 
In this work we detail a methodology to address these problems with biological data hoping that will 
improve the reproducibility of the experiments.  
  
2 MATERIALS AND METHODS  
2.1 Methodology design  
The main aim of this work is to present a methodology, Figure 1 of analysis of multiomics data for the 
design of experiments by means of Machine Learning algorithms. This methodology will provide a 
standardized solution for the study of metastatic stages of different types of cancer. The ML problems 
addressed here consist of supervised learning.  
 
 
 
Figure 1: Overall methodology scheme 
  
Generally speaking, most used data sources in cancer research are among others: expression, 
mutation, methylation, genomic sequence, microbiome, protein and metabolome.  
 
Initially, omic data sources have a high number of dimensions and ML algorithms are not 
especifically design to deal with that huge number of them. In fact, those algorithms in general do not 
achieve good performance scores with high-dimensional data or correlated factors. We proposed two 
different approaches for the reduction of the number of factors for each omic source: biological and 
mathematical filter.  
 
Using the first filter, our proposal is to reduce the number of genes using biological previous 
published information. In the case of non genetic data sources such as Methylation, Single Nucleotide 
Polymorphism (SNP) or Copy Number Aberration (CNA) data we propose the use of an eQTL 
(Expression quantitative trait loci) analysis to obtain the cis CpGs islands that are higher correlated with 
the filtered genes. For example, in the case of miRNA data, specific databases, such as miRBase are 
available to obtain miRNA molecules of interest. Finally, with the remaining biological related factors is 
time to use a mathematical filter. To this aim, our proposal is to use a univariate filter Feature Selection 
(FS) approach mainly because its faster and independent of the ML algorithm.  
 
Therefore, once the dataset is generated according with biological and mathematical information, 
several different algorithms must be trained in order to perform a fair comparison of the results, this step 
should be planned carefully. For the training phase, a nested resampling must be used. This process is 
proposed in two levels: an independent external cross-validation to evaluate the generalization capability 
of the model and avoid overfitting and an internal cross-validation for the selection of the best 
hyperparameters for each algorithm. The performance of the models can be evaluated through several 
measures such as, area under curve ROC (AUC), accuracy, sensitivity, specificity, etc. AUC is one the 
most robust performance measures because is independent of the binarization threshold and considers at 
the same tiem Type I and Type II errors.  
2.2 Omic data sources  
There are a multitude of free access omic data sources repositories, where researchers can download 
the data to perform their own ML experiments. In this paper we will focus on The Cancer Genome Atlas 
(TCGA) [1], since it is the most complete repository to date of cancer-related data. Big data repositories 
such as TCGA, an open database with multiple sources of omic data from different types of cancer, 
provide to researchers the ability and ease of downloading a lot of different omic data types [5, 6]. These 
platforms allow researches to develop and test bioinformatic pipelines with real data.  
 
TCGA initiative has 33 types of cancer and more than seven different data sources. Among them are 
expression, methylation, mutation, CNA, SNP, miRNA, RNAseq and protein data and also clinical 
information. Therefore we are able to define the patients through T, N or M Metastatic Stages in 
metastasis research. These stages determine the metastasis stage of the patients. Thus, we can differentiate 
patients without metastasis (n0, t0 or m0) from those with metastasis (n1, n2, n3; t1, t2, t3 and m1, m2, 
m3). 
2.3 Data pre-processing  
First, those patients with a defined TNM Stage must be selected. Therefore those patients with an NA 
stage are deleted. Because within each stage there are different substates, these should be grouped in the 
common stage. For instance, patients with stages ’n0 (i-)’ or ’no (i +)’ are grouped in stage n0. 
Subsequently, only patients with primary tumor samples were selected. In this step data visualization 
(Principal Component Analysis or Multidimensional Scale) is recommended to detect outliers patients 
and decide if these patients are to be included or not in the analysis. In addition, prior to ML experiments, 
data should be scaled and constant variables removed.   
2.4 Dimensionality reduction  
In a high dimensional dataset, some features may be redundant or correlated and some noise can 
occur. To take better advantage of the space of the solutions, the quantity of useless factors must be 
reduced to the maximum. In this work, two different approaches are proposed to this aim. The first one is 
the use of a biologic data-driven approach, while the second was performed only with mathematical 
information, without any biological information of the factors.  
 
The objective of the biological filter is to extract a subset of factors CpGs islands, etc.) related to the 
biological problem, in this case, the metastasis process. This subset of features can be obtained from 
different initiatives such as The Human Protein Atlas (HPA) [10], Kyoto Encyclopedia of Genes and 
Genomes (KEGG) [3], Wikipathways [9], etc. These initiatives classify genes through location, metabolic 
process, function, etc.  
 
After this reduction of dimensionality, the number of factor is potentially much higher than the 
number of observations. In ML, there are three main approaches for FS: filter, wrapped and embedded 
[8]. The main difference between the filter approach and the others is that the filter is independent of the 
algorithm. In this work we proposed the use of a univariate filter feature selection approach due also to its 
speed and simplicity. There are other approaches for dimensionality reduction in ML but FS retains the 
meaning of the factors.  
2.5 Machine Learning  
Machine learning is the field of study interested in the development of computational algorithms 
capable of transforming data into intelligent actions. This field is extensive in several areas, as it helps to 
explain and extract specific knowledge from a set of observations that humans would not be able to easily 
perform by themselves. There are mainly two types of learning: supervised and unsupervised. The 
principal difference between them is that in the former, learning occurs via labeled observations, while in 
the latter, the examples are not labeled, and the algorithm seeks to cluster the data into different groups.  
 
The number of ML algorithms is increasing day by day, and each of them has a particular set of 
hyperparameters that should be tuned to find the best possible combination and, consequently, the best 
solution to the problem. ML algorithms are very powerful techniques, but the training process is critical. 
This kind of algorithms learn with samples, so the same samples should not be used for learning, 
validation or hyperparameter tuning.  
 
Hence, a two levels nested resampling is recommended. As mentioned before, this type of resampling 
consists in an external cross- validation and an independent internal cross-validation for hyper- parameter 
tuning.  
2.6 Best model determination  
The final step in the proposed methodology is the statistical significance comparison of the 
performance of the machine learning models. Winner model should be identified using statistical tests to 
evaluate the statistical significance. Parametric tests have more power than non-parametric tests but, 
unfortunately, can be used only under certain circumstances (independence, normality and het- 
erocedasticity). If one of the conditions is not met, a non-parametric test must be performed. In addition, a 
post hoc procedure must be used to correct and adjust p-values for multiple comparisons.  
  
2.7 Analysis of the importance of the solution  
Finally, an analysis of the importance of each factor in the model must be performed. The main 
objective is to understand the weight of each factor in the best model. Final signature should be compared 
with previous findings in the scientific literature. With our approach, another point of interest is to 
analyze which factors were selected by the biological and the mathematical filters.  
3 CONCLUSIONS  
In very high dimensional omic problems, the number of factors need to be reduced as much as 
possible without renouncing to the underlying biological information of the issue under analysis. Besides, 
the use of open databases of omic data sources to valorize the economic expenditure and design new 
pipelines/analytical techniques is vitally important. The genes associated with the type of cancer under 
study can be filtered with a biological approach considering specific functions and/or locations. In 
addition, other data types such as SNP, CNA or methylation can be filtered through eQTL analysis to 
reduce the number of variables to only those directly associated with the genes of interest.  
 
The integration of biologically-based omic data sources and the subsequent selection of factors using 
automated learning techniques improve the understanding and identification of cancer metastasis. These 
ML techniques give us more knowledge about analyzed problem than conventional statistical techniques.  
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